Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ferrozzi

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
American Journal of Medical Genetics|August 18, 2000
Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1)M Sigorini, G Zuccoli, F Ferrozzi, et al.
British Journal of Cancer|January 1, 1997
Effectiveness of very low doses of immunotherapy in advanced renal cell cancerC Buzio, G De Palma, R Passalacqua, et al.
Cancer|December 18, 2001
Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinomaC Buzio, S Andrulli, R Santi, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
The study of visual evoked potentials in patients with thyroid-associated ophthalmopathy identifies asymptomatic optic nerve involvementM Salvi, E Spaggiari, F Neri, et al.
La Radiologia Medica|April 1, 1996
[AIDS-related neoplasms: a clinico-radiological study]F Ferrozzi, F Campodonico, D Bova, et al.
Radiology|March 1, 1996
Cystic fibrosis: MR assessment of pancreatic damageF Ferrozzi, D Bova, F Campodonico, et al.
British Journal of Cancer|April 12, 2014
Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagyM I Koukourakis, A Giatromanolaki, A Bottini, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
American Journal of Medical Genetics|August 18, 2000
Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1)M Sigorini, G Zuccoli, F Ferrozzi, et al.
British Journal of Cancer|January 1, 1997
Effectiveness of very low doses of immunotherapy in advanced renal cell cancerC Buzio, G De Palma, R Passalacqua, et al.
Cancer|December 18, 2001
Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinomaC Buzio, S Andrulli, R Santi, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
The study of visual evoked potentials in patients with thyroid-associated ophthalmopathy identifies asymptomatic optic nerve involvementM Salvi, E Spaggiari, F Neri, et al.
La Radiologia Medica|April 1, 1996
[AIDS-related neoplasms: a clinico-radiological study]F Ferrozzi, F Campodonico, D Bova, et al.
Radiology|March 1, 1996
Cystic fibrosis: MR assessment of pancreatic damageF Ferrozzi, D Bova, F Campodonico, et al.
British Journal of Cancer|April 12, 2014
Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagyM I Koukourakis, A Giatromanolaki, A Bottini, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
Pageof 11